Using MRI to improve treatment decisions for early breast cancer
MRI Radiomic Signatures of DCIS to Optimize Treatment
This study is looking at how special MRI images can help doctors tell the difference between low-risk and high-risk cases of ductal carcinoma in situ (DCIS), the earliest stage of breast cancer, so that women can get the right treatment without going through unnecessary procedures.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10874568 on NIH RePORTER |
What this research studies
This research investigates how MRI radiomic features can help optimize treatment for ductal carcinoma in situ (DCIS), the earliest form of breast cancer. By analyzing MRI images, the study aims to better distinguish between low-risk and high-risk cases of DCIS, which could reduce unnecessary treatments for many women. The approach focuses on understanding the biological characteristics of tumors and their surrounding environment, which are often missed by traditional imaging methods. This could lead to more personalized treatment plans and less anxiety for patients diagnosed with DCIS.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with ductal carcinoma in situ (DCIS) who are facing treatment decisions.
Not a fit: Patients with invasive breast cancer or those not diagnosed with DCIS may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce overtreatment and improve the quality of life for women diagnosed with DCIS.
How similar studies have performed: Previous research has shown promise in using imaging techniques to improve cancer treatment decisions, making this approach both innovative and grounded in prior successes.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Rahbar, Habibollah — University of Washington
- Study coordinator: Rahbar, Habibollah
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.